Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,448 | -18,350 | -9,983 | -9,909 | -7,662 |
| Depreciation Amortization | 7,193 | 3,590 | 2,438 | 1,233 | 1,117 |
| Accounts receivable | -8,004 | N/A | N/A | N/A | N/A |
| Other Working Capital | 5,172 | -4,740 | 11,924 | 3,610 | 1,220 |
| Other Operating Activity | 18,753 | 280 | 600 | -752 | 0 |
| Operating Cash Flow | $-15,334 | $-19,220 | $4,979 | $-5,818 | $-5,325 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -46,649 | N/A | N/A | N/A | N/A |
| PPE Investments | -20,502 | -34,580 | -17,261 | -2,181 | -1,340 |
| Purchase Sale Intangibles | -15,288 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -15,288 | 28,080 | -67,452 | -1,660 | -12,180 |
| Investing Cash Flow | $-82,439 | $-6,500 | $-84,713 | $-3,841 | $-13,520 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 104,806 | N/A | N/A | N/A | N/A |
| Debt Repayment | -64 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,545 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 36,530 | 76,114 | 24,393 | 12,169 |
| Financing Cash Flow | $106,287 | $36,530 | $76,114 | $24,393 | $12,169 |
| Beginning Cash Position | 24,916 | 14,100 | 18,568 | 3,834 | 10,510 |
| End Cash Position | 33,430 | 24,910 | 14,948 | 18,568 | 3,834 |
| Net Cash Flow | $8,514 | $10,810 | $-3,620 | $14,734 | $-6,676 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,334 | -19,220 | 4,979 | -5,818 | -5,325 |
| Capital Expenditure | -20,502 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -35,836 | -19,220 | 4,979 | -5,818 | -5,325 |